Fangming Gu

1.6k total citations
44 papers, 1.3k citations indexed

About

Fangming Gu is a scholar working on Molecular Biology, Oncology and Hepatology. According to data from OpenAlex, Fangming Gu has authored 44 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Oncology and 13 papers in Hepatology. Recurrent topics in Fangming Gu's work include Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Polymer crystallization and properties (11 papers) and Material Dynamics and Properties (5 papers). Fangming Gu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Polymer crystallization and properties (11 papers) and Material Dynamics and Properties (5 papers). Fangming Gu collaborates with scholars based in China, Japan and Hong Kong. Fangming Gu's co-authors include Akihiko Toda, Masamichi Hikosaka, Jia Fan, Haishan Bu, Jian Zhou, Shinichi Yamazaki, Jiahao Jiang, Qiang Gao, Quan‐Lin Li and Koji Yamada and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Hepatology.

In The Last Decade

Fangming Gu

44 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fangming Gu China 19 373 332 277 238 182 44 1.3k
Xiaofei Zhang China 22 146 0.4× 691 2.1× 285 1.0× 450 1.9× 201 1.1× 55 1.7k
Fang Xie China 21 68 0.2× 489 1.5× 451 1.6× 133 0.6× 611 3.4× 49 1.6k
Tongyi Huang China 17 32 0.1× 311 0.9× 208 0.8× 217 0.9× 223 1.2× 37 1.2k
Serena Mancarella Italy 17 26 0.1× 507 1.5× 312 1.1× 262 1.1× 146 0.8× 27 1.1k
Jurstine Daruwalla Australia 11 108 0.3× 441 1.3× 169 0.6× 111 0.5× 59 0.3× 17 1.3k
Qi Bao China 17 56 0.2× 448 1.3× 170 0.6× 66 0.3× 303 1.7× 37 925
Yu Yao China 24 43 0.1× 743 2.2× 378 1.4× 326 1.4× 207 1.1× 62 1.6k
Stéphanie Lacotte Switzerland 19 31 0.1× 316 1.0× 161 0.6× 58 0.2× 300 1.6× 52 1.6k
Zhengkui Zhang China 19 40 0.1× 935 2.8× 245 0.9× 479 2.0× 166 0.9× 27 1.4k

Countries citing papers authored by Fangming Gu

Since Specialization
Citations

This map shows the geographic impact of Fangming Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangming Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangming Gu more than expected).

Fields of papers citing papers by Fangming Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangming Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangming Gu. The network helps show where Fangming Gu may publish in the future.

Co-authorship network of co-authors of Fangming Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Fangming Gu. A scholar is included among the top collaborators of Fangming Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangming Gu. Fangming Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fu, Siyuan, Dapeng Sun, Zongyan Wang, et al.. (2024). METTL3-Mediated m 6 A Modification of FMRP Drives Hepatocellular Carcinoma Progression and Indicates Poor Prognosis. Cancer Biotherapy and Radiopharmaceuticals. 39(10). 745–754. 1 indexed citations
2.
Sun, Dapeng, Wen Li, Zongyan Wang, et al.. (2024). IL-17a promotes hepatocellular carcinoma by increasing FAP expression in hepatic stellate cells via activation of the STAT3 signaling pathway. Cell Death Discovery. 10(1). 230–230. 9 indexed citations
3.
4.
Huang, Jian, Zhenguang Wang, Qi-fei Tao, et al.. (2023). Efficacy and safety of Lenvatinib-based combination therapies for patients with unresectable hepatocellular carcinoma: a single center retrospective study. Frontiers in Immunology. 14. 1198562–1198562. 1 indexed citations
5.
6.
Liu, Lei, Xiaojie Gan, Wen‐Bin Ding, et al.. (2022). Development of preoperative prognostic models including radiological features for survival of singular nodular HCC patients. Hepatobiliary & pancreatic diseases international. 22(1). 72–80. 4 indexed citations
7.
Liu, Huiying, Fuchen Liu, Fangming Gu, et al.. (2021). Circulating Tumor Cells Expressing Krüppel-Like Factor 8 and Vimentin as Predictors of Poor Prognosis in Pancreatic Cancer Patients. Cancer Control. 28. 2895445211–2895445211. 12 indexed citations
8.
9.
Yang, Yun, Meng‐chao Wang, Tian Tao, et al.. (2020). A High Preoperative Platelet-Lymphocyte Ratio Is a Negative Predictor of Survival After Liver Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma: A Retrospective Study. Frontiers in Oncology. 10. 576205–576205. 18 indexed citations
10.
Xu, Qingguo, Shengxian Yuan, Qi-fei Tao, et al.. (2019). A novel HBx genotype serves as a preoperative predictor and fails to activate the JAK1/STATs pathway in hepatocellular carcinoma. Journal of Hepatology. 70(5). 904–917. 20 indexed citations
11.
12.
Jiang, Jiahao, Yanfeng Liu, Ai‐Wu Ke, et al.. (2014). Clinical significance of the ubiquitin ligase UBE3C in hepatocellular carcinoma revealed by exome sequencing. Hepatology. 59(6). 2216–2227. 37 indexed citations
13.
Li, Quan‐Lin, Fangming Gu, Zheng Wang, et al.. (2012). Activation of PI3K/AKT and MAPK Pathway through a PDGFRβ-Dependent Feedback Loop Is Involved in Rapamycin Resistance in Hepatocellular Carcinoma. PLoS ONE. 7(3). e33379–e33379. 50 indexed citations
14.
Gu, Fangming, Qiang Gao, Guo‐Ming Shi, et al.. (2012). Intratumoral IL-17+ Cells and Neutrophils show Strong Prognostic Significance in Intrahepatic Cholangiocarcinoma. Annals of Surgical Oncology. 19(8). 2506–2514. 87 indexed citations
15.
Gu, Fangming, Quan‐Lin Li, Qiang Gao, et al.. (2011). IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma. Molecular Cancer. 10(1). 150–150. 190 indexed citations
16.
Gu, Fangming. (2011). Sorafenib inhibits growth and metastasis of hepatocellular carcinoma by blocking STAT3. World Journal of Gastroenterology. 17(34). 3922–3922. 72 indexed citations
17.
Huang, Xiaoyong, Ai‐Wu Ke, Guo‐Ming Shi, et al.. (2010). Overexpression of CD151 as an adverse marker for intrahepatic cholangiocarcinoma patients. Cancer. 116(23). 5440–5451. 39 indexed citations
18.
Xu, Min, Chang‐Jun Tan, Jian Zhou, et al.. (2009). The dynamic changes of T-bet+/GATA-3+ and RORγt+/FOXP3+ cells in recipient spleens and grafts after rat orthotopic liver transplantation. Transplant Immunology. 22(3-4). 165–171. 7 indexed citations
19.
Bu, Haishan, Fangming Gu, Lirong Bao, & Min Chen. (1998). Influence of Entanglements on Crystallization of Macromolecules. Macromolecules. 31(20). 7108–7110. 65 indexed citations
20.
Gu, Fangming, Haishan Bu, & Ze Zhang. (1998). Unique morphologies found in freeze-dried poly(ethylene oxide) prepared from dilute solutions. Macromolecular Chemistry and Physics. 199(11). 2597–2600. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaofei Zhang Breakdown of academic impact, for papers by Fang Xie Breakdown of academic impact, for papers by Tongyi Huang Breakdown of academic impact, for papers by Serena Mancarella Breakdown of academic impact, for papers by Jurstine Daruwalla Breakdown of academic impact, for papers by Qi Bao Breakdown of academic impact, for papers by Yu Yao Breakdown of academic impact, for papers by Stéphanie Lacotte Breakdown of academic impact, for papers by Zhengkui Zhang
Rankless by CCL
2026